• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Nosocomial transmission of SARS-CoV-2 from infected symptomatic children to uninfected caregivers: A retrospective cohort study

tetano

Editor, Senior Moderator
J Infect Chemother


. 2022 Dec 2;S1341-321X(22)00320-8.
doi: 10.1016/j.jiac.2022.11.013. Online ahead of print.
Nosocomial transmission of SARS-CoV-2 from infected symptomatic children to uninfected caregivers: A retrospective cohort study in a Japanese tertiary children's hospital


Akihiko Shimizu[SUP] 1 [/SUP], Sachiko Kitazume[SUP] 2 [/SUP]



Affiliations

Abstract

Background: The transmission rate of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear when caregivers accompany pediatric COVID-19 patients in the same isolation room in a hospital setting.
Aim: We investigated SARS-CoV-2 transmission from infected children to caregivers at our hospital.
Methods: This retrospective cohort study included 34 discordant pairs of patients admitted between September 2020 and April 2022.
Findings: The median ages of the children and caregivers were 3.7 years (interquartile range [IQR]: 1.6-8.1) and 33.1 years (IQR: 28.3-43.4), respectively. Of the 34 caregivers, 31 were mothers, two were fathers, and one was a relative. Sixteen caregivers received at least two doses of the mRNA vaccine. The mean duration of the hospital stays was 7.7 ± 4.1 days (range: 3-19). Two unvaccinated caregivers developed COVID-19 after admission; the onset was within 48 hours after admission. It is likely that they had been infected in their household prior to admission, since the incubation period for COVID-19 is usually >2 days.
Conclusions: Nosocomial SARS-CoV-2 transmission from infected children to caregivers was not confirmed in this study. The combination of negative-pressure rooms, vaccinations, and infection-control bundles appears to be effective at preventing SARS-CoV-2 transmission. It is acceptable to allow caregivers to accompany pediatric COVID-19 patients in a hospital ward if they can comply with basic infection control measures.

Keywords: COVID-19; Caregivers; Nosocomial transmission; Pediatric; SARS-CoV-2.
 
Back
Top Bottom